#ChopViolence/#ChopHIV
Launched by HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · Feb 23, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The #ChopViolence/#ChopHIV clinical trial is focused on improving HIV care and reducing violence among Black young gay, bisexual, and other men who have sex with men (B-YGBMSM) and transgender women (B-YTW) in the House Ball Community (HBC) in Chicago. This group is at a higher risk for HIV and often faces barriers to accessing healthcare, including violence. The trial aims to create and test a new program that addresses these issues by training trusted community members to intervene in violent situations and connect individuals with HIV care.
To participate in the trial, individuals must be Black, aged 15 to 29, and attend events in the HBC. Participants can expect to engage in discussions about violence and HIV, receive support from trained outreach workers, and be part of follow-up assessments to track progress. The goal of this trial is to create a safer environment that encourages better health outcomes for those at risk of HIV, ultimately leading to improved access to care and support within the community.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. self-identified as Black,
- • 2. ages 15-29
- • 3. in attendance at a HBC event at the time of the assessment.
- Exclusion Criteria:
- • -
About Hektoen Institute For Medical Research
The Hektoen Institute for Medical Research is a leading nonprofit organization dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a commitment to fostering collaboration among scientists, clinicians, and community stakeholders, the Institute focuses on a wide range of health-related studies, including clinical trials that explore novel therapies and interventions. By leveraging cutting-edge methodologies and a robust network of experts, the Hektoen Institute aims to translate research findings into practical solutions that address pressing health challenges and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials